Forest Laboratories’ Irish subsidiary records loss

The main Irish subsidiary of pharmaceutical firm, Forest Laboratories, plunged into the red last year to record pre-tax losses of $138.42m (€126.29m).

This followed revenues at the Dublin-based firm decreasing by 36.5% from $2.48bn to $1.57bn in the nine months to the end of last December, compared to the prior 12-month period.

The loss followed a pre-tax profit of $426.4m in 2013, a negative swing of $564m.